Not a Lexis Advance subscriber? Try it out for free.

Hikma Pharms. USA Inc. v. Vanda Pharms. Inc.

Supreme Court of the United States

January 13, 2020, Decided

No. 18-817.

Opinion

Petition for writ of certiorari to the United States Court of Appeals for the Federal Circuit denied.

Read The Full CaseNot a Lexis Advance subscriber? Try it out for free.

Full case includes Shepard's, Headnotes, Legal Analytics from Lex Machina, and more.

2020 U.S. LEXIS 98 *; 140 S. Ct. 911; 205 L. Ed. 2d 454; 2020 WL 129534

Hikma Pharmaceuticals USA Inc., et al., Petitioners v. Vanda Pharmaceuticals Inc.

Prior History: Vanda Pharms. Inc. v. West-Ward Pharms. Int'l Ltd., 887 F.3d 1117, 2018 U.S. App. LEXIS 9360 (Fed. Cir., Apr. 13, 2018)

Judges:  [*1] Roberts, Thomas, Ginsburg, Breyer, Alito, Sotomayor, Kagan, Gorsuch, Kavanaugh.